Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis

2 Jul 2020

Abstract excerpt

Pancreatic cancer is an aggressive, solid tumor, with a grave prognosis. Despite surgical treatment in patients with pancreatic cancer, the rate of recurrence is high. In addition, although tumor biomarkers are frequently used to confirm advanced pancreatic cancer, this is not accurate and the biomarkers currently used cannot indicate prognosis. This study sought to evaluate circulating tumor DNA as a tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Pancreatic and Hepatic Oncology Research
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32614932
DOI: 10.1371/journal.pone.0235623

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasisPMID 32614932Read ↗

Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic Cancer.Semantic proximity Read ↗

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.Semantic proximity Read ↗

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Semantic proximity Read ↗

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations.Semantic proximity Read ↗

Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.Semantic proximity Read ↗

Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.Semantic proximity Read ↗

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas.Semantic proximity Read ↗

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlationsSemantic proximity Read ↗

Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.Semantic proximity Read ↗

Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic CancerSemantic proximity Read ↗

[Progress of circulating tumor DNA in diagnosis and prognosis of pancreatic cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.